StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$2.23−0.04 (-1.76%)

Close on Nov 13, 2026Market cap $3.37MP/E –Yield –

Earnings

Apimeds Pharmaceuticals US's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Apimeds Pharmaceuticals US's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Apimeds Pharmaceuticals US has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Apimeds Pharmaceuticals US puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Apimeds Pharmaceuticals US filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE ISSUED BY MINDWAVE INNOVATIONS INC. DATED OCTOBER 4, 2026 (BLOCKASSURE)
    News
  2. PRESS RELEASE ISSUED BY MINDWAVE INNOVATIONS INC. DATED SEPTEMBER 24, 2026 (AQUAECHAIN)
    News
  3. PRESS RELEASE ISSUED BY MINDWAVE INNOVATIONS INC. DATED SEPTEMBER 29, 2026 (FLASHCHAIN)
    News
  4. PRESS RELEASE ISSUED BY MINDWAVE INNOVATIONS INC. DATED MARCH 24, 2026
    News
  5. PRESS RELEASE, DATED DECEMBER 1, 2025
    Update
  6. PRESS RELEASE DATED JULY 15, 2025
    Update
  7. PRESS RELEASE, DATED MAY 8, 2025
    Update
  8. PRESS RELEASE, DATED MAY 12, 2025
    Update

See a number that looks wrong?